Reports

12900 Results (Page 20 of 516)

All Market Research Reports

Healthcare Services

Portugal Cancer Pain Management Market Analysis

This report presents a strategic analysis of the Portugal Cancer Pain Management Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Portugal Cancer Pain Management Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

Japan Rheumatology Drugs Market Analysis

The Japan Rheumatology Drugs Market is projected to grow from $3.795 Bn in 2022 to $4.920 Bn by 2030, registering a CAGR of 3.30% during the forecast period of 2022-2030. Leading companies working on new treatments for rheumatoid arthritis include Taisho Pharmaceuticals, R-Pharm, GlaxoSmithKline, Aclaris Therapeutics, Pfizer, Abivax, Bristol-Myers Squibb, Oscotec/Genosco, Mesoblast, Pfizer Akros Pharma/Japan Tobacco, Abbvie, Horizon Therapeutics, Eli Lilly and Company, Taiho Pharmaceutical, Gilead Sciences, Kiniksa Pharmaceutical

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Rare Diseases

Japan Herpes Simplex Virus Therapeutics Market Analysis

Japan Herpes Simplex Virus Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. Herpes simplex virus (HSV) is a common viral infection that can cause a range of diseases in humans. High Prevalence of HSV Infections, Increasing Awareness and Diagnosis, Continued research and development efforts, Technological advancements and Increasing healthcare expenditure, particularly in developed countries, provides a supportive environment for the growth of the HSV Therapeutics market. Social stigma surrounding herpes, Drug-resistant HSV strains provided by limited treatment options are restraining factors in herpes simplex therapeutics market. GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Novartis AG, AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd. Are global key players in herpes simplex therapeutics market.

PUBLISHED: Jul, 2023 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Rare Diseases

China Mucopolysaccharidosis I (MPS-I) Therapeutics Market Analysis

China Mucopolysaccharidosis I (MPS-I) therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. Rising consumer awareness, new drug approvals, enticing reimbursement plans, an established healthcare system, and the presence of sizable market competitors all drive the market for treating Mucopolysaccharidosis I. Major global players in this market are Takeda Pharmaceutical Company Limited, BioMarin Pharmaceuticals, Inc., Ultragenyx Pharmaceutical Inc., Sarepta Therapeutics, Abeona Therapeutics, Eloxx Pharmaceuticals, Esteve, Immusoft Corporation, Inventiva, GC Pharma, JCR Pharmaceuticals Co Ltd., RegenxBio Inc., Sangamo Therapeutics, Inc., Bioasis Technologies Inc., and Paradigm Biopharmaceuticals Ltd.

PUBLISHED: Jul, 2023 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Digital Health

Portugal Blockchain Technology in Healthcare Market Analysis

This report presents a strategic analysis of the Portugal Blockchain Technology in Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Portugal Blockchain Technology in Healthcare Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Digital Health

Russia Artificial Intelligence (AI) in Healthcare Market Analysis

This report presents a strategic analysis of Russian artificial Intelligence (AI) in the Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about Russia's Artificial Intelligence (AI) in the Healthcare Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Digital Health

Venezuela Telemedicine Market Analysis

This report presents a strategic analysis of the Venezuela Telemedicine Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Venezuela Telemedicine Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

Global Contraceptive Devices Market Analysis

This report presents a strategic analysis of the Global Contraceptive Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Global Contraceptive Devices Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Digital Health

Global Blockchain Technology in Healthcare Market Analysis

This report presents a strategic analysis of the Global Blockchain Technology in the Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Global Blockchain Technology in the Healthcare Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

Global Cardiovascular Diseases Therapeutics Market Analysis

This report presents a strategic analysis of the Global Cardiovascular Diseases Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Global Cardiovascular Diseases Therapeutics Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Digital Health

Egypt Artificial Intelligence (AI) in Diagnostics Market Analysis

Egypt's Artificial Intelligence (AI) in the diagnostics market is projected to grow from $2.8 Mn in 2022 to $33.75 Mn by 2030, registering a CAGR of 36.5% during the forecast period of 2022-2030. The market will be driven by the country's attempts to improve ’s entire healthcare system, as well as the significant demand for modern diagnostic solutions. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Siemens Healthineers & Lunit Inc.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Rare Diseases

Japan Chronic Inflammatory Demyelinating Polyneuritis Therapeutics Market Analysis

Japan Chronic Inflammatory Demyelinating Polyneuritis Therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. A acquired immune-mediated neuropathy that affects peripheral nerves and nerve roots, chronic inflammatory demyelinating polyneuropathy (CIDP; also known as chronic inflammatory demyelinating polyradiculoneuropathy) is characterised by a progressive or relapsing-remitting course of symmetric weakness of the proximal and distal muscles. Growing government spending and disease awareness have been the market's main drivers for Chronic Inflammatory Demyelinating Polyneuritis (CIDP) Therapeutics. Bio products laboratory Ltd., Momenta Pharmaceuticals, Grifols, Baxter, Octapharma, Shire, Kedrion SPA, Misubishi Tanabe Pharma Corporation, CSL Behring, and Teijin Pharma Ltd. are global firms in the Chronic Inflammatory Demyelinating Polyneuritis (CIDP) Therapeutics market.

PUBLISHED: Jul, 2023 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Rare Diseases

Japan Charcot-Marie-Tooth Disease (CMT) Therapeutics Market Analysis

Japan Charcot-Marie-Tooth Disease (CMT) Therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. The majority of hereditary peripheral neuropathies are Charcot-Marie-Tooth (CMT) illness, commonly referred to as hereditary motor and sensory neuropathy (HMSN). Genes that support or generate proteins important in the construction and operation of the myelin sheath or the peripheral nerve axon are mutated, leading to CMT. An increase in genetic illnesses will result in more innovations being made in this area, which will enhance market growth because there are many genes that cause these problems. The above-mentioned forecast period will witness the emergence of the market for Charcot Marie-Tooth disease due to multiple prospects that will be heightened by the rising focus on targeted therapies and the favorable government regulations. Addex Therapeutics Ltd., Affectis Pharmaceuticals AG, Genzyme Corp., Lead Discovery Center GmbH, Pharnext SA, Acceleron Pharma, MedDay Pharmaceuticals, Bristol-Myers-Squibb Company, Inflectis Bio Science Health Company, Helixmith Co., Ltd., and Neurogene Inc. are some of the major players in the Charcot Marie Tooth Disease Market.

PUBLISHED: Jul, 2023 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Rare Diseases

Japan Batten's Disease (CLN-2) Therapeutics Market Analysis

Japan Batten?s Disease (CLN-2) Therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Neuronal Ceroid Lipofuscinosis (NCL), often known as Batten disease, is a rare and severe autosomal recessive neurodegenerative lysosomal storage condition brought on by cellular buildup of aberrant auto-fluorescent lipoproteins (lipofuscin). Seizures and a progressive loss of movement, verbal, visual, and cognitive abilities are features of this neurodegenerative condition that primarily affects the nerve system. Research advancements in nanotechnology could result in the creation of fresh therapies that would benefit persons who suffer from this ailment. Additionally, it is a paediatric brain condition that is extremely rare yet progresses quickly. As a result, Batten's Disease may be exacerbated by the predicted rising prevalence of disease. Therapeutics market (CLN-2). The market for Batten's Disease (CLN-2) Therapeutics is constrained by a lack of treatment and symptoms that are challenging to identify. Regenxbio, Polaryx Therapeutics and Abeona Therapeutics are some of the key players in the market.

PUBLISHED: Jul, 2023 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Healthcare Services

Vietnam Genomics Market Analysis

The Vietnam Genomics market was valued at $163.2 Mn in 2023 and is predicted to grow at a CAGR of 16.73% from 2023 to 2030, to $482.1 Mn by 2030. The key drivers of the market include increasing public awareness, the need for advancements in cancer treatments, and increasing trend of personalized medicines. The prominent players of the Vietnam genomics market are Gene Solutions, Medics Genetics, Vinmec Research Institute of Stem Cell and Gene Technology (VRISG), and Medical Genetics Institute (MGI), among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Healthcare Services

Saudi Arabia Genomics Market Analysis

The Saudi Arabia Genomics market was valued at $555.1 Mn in 2023 and is predicted to grow at a CAGR of 18% from 2023 to 2030, to $1,768.1 Mn by 2030. The key drivers of the market include rising prevalence of diseases, increasing applications of genomics, the need for advancements in cancer treatments, and the rising demand for personalized medicines. The prominent players of the Saudi Arabia Genomics Market are NoorDx, Al Farabi Labs, Novo Genomics, Anwa Labs, Saudi Advanced Medical Lab (SAML), Saudi-German Genomic Centre, among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Healthcare Services

Mexico Genomics Market Analysis

The Mexico Genomics market was valued at $489.8 Mn in 2023 and is predicted to grow at a CAGR of 16.75% from 2023 to 2030, to $1,448 Mn by 2030. The key drivers of the market include the need for advancements in cancer treatments, increasing trend of personalized medicines, and increasing genomics projects. The prominent players of the Mexico genomics market are National Institute of Genomic Medicine (INMEGEN), the National Laboratory of Genomics for Biodiversity of Mexico (LANGEBIO), Genomica Medica, BGI Mexico, and National Autonomous University of Mexico (UNAM), among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Healthcare Services

Kenya Genomics Market Analysis

The Kenya Genomics market was valued at $22.9 Mn in 2023 and is predicted to grow at a CAGR of 17.6% from 2023 to 2030, to $71.1 Mn by 2030. The key drivers of the market include the growing infectious disease burden, the need for advancements in cancer treatments, and the increasing trend of personalized medicines. The prominent players of the Kenya Genomics Market are Kenyatta National Hospital (KNH), Kenya Medical Research Institute (KEMRI), Bioinformatics Institute of Kenya (KIBS), Illumina, Thermo Fisher Scientific, Qiagen, and Agilent, among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Lipid Disorder Therapeutics Market Analysis

The Egypt Lipid Disorder Therapeutics Market was valued at $65.7 Mn in 2023 and is predicted to grow at a CAGR of 13.86% from 2023 to 2030, to $162.9 Mn by 2030. Egypt's Lipid Disorder Therapeutics Market is growing due to the Rising Prevalence of Non-Communicable Diseases, Growing Awareness and Focus on Chronic Disease Management, and Rising Demand for Digitalized Healthcare Services. The industry is primarily dominated by players such as Sanofi, Sun Pharmaceutical Industries Ltd., Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Rare Diseases

Japan ATTR (Transthyretin Amyloidosis) Therapeutics Market Analysis

Japan ATTR (Transthyretin Amyloidosis) Therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. An rare and progressive condition known as ATTR (Transthyretin Amyloidosis) is characterised by the buildup of aberrant proteins in the body, including misTTR. The market for treatments for transthyretin amyloidosis is primarily driven by the expansion of the population and the availability of favourable reimbursement programmes. The market is predicted to increase as a result of strategic actions done by major players such raising knowledge of the target conditions like ATTR and the long-term advantages of treatments that are currently accessible. The market for treating transthyretin amyloidosis is currently constrained by a number of factors, including low awareness of the condition in developing nations, misdiagnosis of the condition, high costs of disease diagnosis and treatment, the lack of adequate clinical trials, and the absence of effective medications. Pfizer Inc., Johnson & Johnson Services, Inc., Ionis Pharmaceuticals, Alnylam Pharmaceuticals, BridgeBio Pharma, Bristol-Myers Squibb Company, Acrotech Biopharma, AstraZeneca, Astellas Pharma, Inc., Prothena, SOM Biotech, and numerous others are global competitors in the ATTR (Transthyretin Amyloidosis) market.

PUBLISHED: Jul, 2023 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Rare Diseases

Japan Ankylosing Spondylitis Therapeutics Market Analysis

Japan Ankylosing Spondylitis Drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. Ankylosing spondylitis is a kind of arthritis that affects connective tissues. The sacroiliac joints, which connect the spine to the pelvis, become inflamed, but in extreme situations, the spine's bones might fuse together and become very inflexible. A rough estimate of 1.1 Mn Americans, or one out of every 200 adults, are impacted. Abbvie, Amgen, Eli Lilly, Janssen, Merck, Pfizer, Novartis, UCB, and many other leading companies are active in the ankylosing spondylitis global market. To increase their market share, these businesses engage in strategic alliances and acquisitions in addition to concentrating on research and development to bring novel therapies to market.

PUBLISHED: Jul, 2023 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Rare Diseases

Japan Adrenoleukodystrophy (ALD) Therapeutics Market Analysis

Japan Adrenoleukodystrophy (ALD) Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. Drivers of acromegaly market are increasing cases of the disorder which in turn increased awareness and government focus motivated financial support to R&D. Poxel SA, Bluebird Bio Inc.,Viking Technologies, Minoryx Therapeutics sl., Apteeus SAS, Ashvattha Therapeutics LLC, NeuroVia Company, Autobahn Therapeutics Inc., Aldagen Inc., Celularity Inc., Imstem Biotechnology Inc., MedDay SA, and Orpheris Inc. are major competitors in the Japan Adrenoleukodystrophy (ALD) drugs market.

PUBLISHED: Jul, 2023 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Healthcare Services

Venezuela Bioinformatics Market Analysis

The Venezuela bioinformatics market is projected to grow from $xx Mn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factor driving the growth would be increased government focus on improving healthcare. The market is segmented by technology and by application. Some of the major players include Partek, Bruker Corporation, NEC, Genedata, and Thermo Fisher Scientific.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

Argentina Acne Drugs Market Analysis

This report presents a strategic analysis of the Argentina Acne Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Argentina Acne Drugs Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Clinical Trials

Denmark Oncology Clinical Trials Market Analysis

This report presents a strategic analysis of the Denmark Oncology Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Denmark Oncology Clinical Trials Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

subscribe to our newsletter
up